Navigation Links
Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
Date:3/3/2008

Initial Analysis Shows Statistically Significant Pain Relief with the 2.5

and 5 mg Doses Compared to Placebo

MOUNTAIN VIEW, Calif., March 3 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today positive top-line results from its 168 patient Phase 2a clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache. Migraine is a debilitating, yet common neurological disorder characterized by attacks of severe headache and autonomic nervous system dysfunction. Two doses of AZ-104, 2.5 and 5 mg, met the primary endpoint of 2-hour pain-relief compared to placebo. Alexza believes the novel, non-invasive nature and rapid pharmacokinetic (PK) properties resulting from inhaled loxapine administration via the Staccato system have the potential to make AZ-104 a viable product to treat acute migraines. AZ-104 is a lower dose version of AZ-004, which is in Phase 3 clinical development for the treatment of acute agitation in patients with schizophrenia or bipolar disorder. AZ-004 and AZ-104 are being developed through Symphony Allegro, a development collaboration formed between Alexza and Symphony Capital in 2006.

"Loxapine is a potent antagonist at dopamine D2 receptors as well as serotonergic 5-HT2A receptors. While drugs that antagonize the D2 receptor are efficacious in treating migraine, it was proposed that the 5HT2A receptor antagonism might yield an improved adverse effect profile over drugs blocking primarily the D2 receptor. This dual mechanism of pharmacological action provided the scientific rationale to study AZ-104 in this proof-of-concept clinical trial," said James V. Cassella, PhD, Senior Vice President, Research and Development at Alexza and chairman
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
10. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 The power of ... important ways in which mankind depends on the plant ... Garden,s multifaceted exhibition Wild Medicine: Healing ... on view from May 18 through September 8, ... The featured exhibition,s many attractions include a re-creation ...
(Date:5/17/2013)... May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... overview at the UBS Global Healthcare Conference in ... May 22 nd at 11 a.m. Eastern Time. To ... presentation, please visit the Investor Relations section of the Company,s ... available for 14 days after the event. About ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
Breaking Medicine Technology:Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Mich., Jan. 23, 2012  Researchers at the University of ... and found that less expensive, more effective tests are ... of patients receiving neuropathy diagnoses undergo high-cost, low-yield MRIs ... according to the study that will be published Jan. ...
... FALLS, N.Y., Jan. 23, 2012  Niagara Thermal Products LLC ... & Sons, Inc. The acquisition brings together two highly ... value custom thermal solutions in the aerospace, defense and ... ) "The addition of Kittredge,s industry recognized ...
Cached Medicine Technology:Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 2Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 3Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 2Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 3
(Date:5/18/2013)... Adolescents, especially young males, who experiment ... “K2” are landing in emergency rooms across America. ... epidemic with a new treatment program for those ... research from the National Institute on Drug Abuse, synthetic ... American teenagers. In 2012, 11 percent of high school ...
(Date:5/18/2013)... Rio Salon and Spa, a ... renovation that features tranquil, Eastern Asian influenced furnishings, decorative ... up, this Morro Bay day spa and ... and comfortable spa beds. Additional salon stations and new ... machine. The shampoo area has been upgraded and ...
(Date:5/18/2013)... Stow, Ohio (PRWEB) May 18, 2013 ... 40th Annual Conference, on May 17-22 in Austin, ... associates gather for educational and networking opportunities. ... cleaning brushes, flexible scope repair capabilities ... presented with valuable educational information on proper instrument ...
(Date:5/18/2013)... Wine World Accessories, a renowned online store ... attractive 25% discount on Franmara Dynamo Electric Wine ... purchase this electric corkscrew opener for $44.95 via Wine ... online store ensures delivery of their items within 1-2 ... , A spokesperson from the online store elaborates the ...
(Date:5/18/2013)... UT (PRWEB) May 18, 2013 Medical device ... orders for its much anticipated mobility aid with its namesake, ... create a hands-free crutch alternative that injured individuals ... broken ankle, for example, can remain active and walk during ... is using its reservation system to ensure those who need ...
Breaking Medicine News(10 mins):Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:FlexLeg Begins Offering New Mobility Aid 2
... Meeting that begins in US today, it is expected ... peek to some very innovative and original dental care ... is also one of the largest exhibitions of oral ... products from 46 countries will include flavored toothpastes, toothbrushes ...
... outbreak of Avian Influenza, commonly called bird flu. Although the //disease ... WHO is skeptical that the strain of virus that causes bird ... the disease human to human, and cause an influenza outbreak that ... first seen in the poultry of Republic of Korea in mid ...
... new study shows invasive procedures do not necessarily ... heart conditions.// ,Researchers studied more than ... for acute coronary syndrome between April 1999 and ... with cardiac catheterization facilities and underwent more invasive ...
... the association between hypogonadism and depression in men age 45 ... 22 percent of the men with low testosterone levels had ... normal levels. The finding held true even after results were ... and prostate cancer, that could have raised the risk for ...
... issue of British Medical Journal say that antidepressant drugs ... attempts.// ,Depression is characterized by a sense ... of self-esteem and confidence, and in the extreme form ... ,Clinical depression, also known as unipolar depression is ...
... twice the risk of heart failure, or a weakening ... to those without rheumatoid arthritis. ,Results of a ... an increased risk for heart failure soon after the ... course of their chronic disease. Researchers also found the ...
Cached Medicine News:
Weitlaner-Locktite retractors, blunt, 11 cm total length....
Weitlaner Beckmann retractor, sharp prongs, SS....
Weitlaner retractor, blunt....
Daubenspeck sharp curette, 8....
Medicine Products: